A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular professional societies provide guidelines for peripheral artery interventions. The purpose of the AUC is...
Cardiovascular Surgery
This channel includes news and new technology innovations for cardiac surgery. This includes coronary bypass grafts, surgical valve replacements.
-
-
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at the ...
-
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-term survival of baboons that had received a heart transplant from genetically...
-
October 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of September 2018.
News | Peripheral Artery Disease (PAD) | December 19, 2018
December 19, 2018 — A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular...
Videos | Advanced Visualization | December 12, 2018
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at...
A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it were greatly alleviate shortages of donor human hearts.
News | Cardiovascular Surgery | December 11, 2018
December 11, 2018 — The scientific journal...
News | Heart Valve Technology | November 02, 2018
November 2, 2018 — Hospitals that routinely perform a...
News | Cardiovascular Surgery | October 25, 2018
October 25, 2018 — On Oct. 18, 2018, LivaNova issued a...
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure | October 19, 2018
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U....
Two of the top videos in September both had to do with interventional cardiology hemodynamic support protocols. The top piece of content in September is an interview on the protocols used to determine what device technology to use at Henry Ford Hospital in Detroit. No. 13 on the list is another video on late-breaking data presented at TCT 2018 from the National Cardiogenic Shock Initiative (NCSI) where mortality was improved by 50 percent over the current standard of care. Pictured here are Abiomed Impella percutaneous ventricular assist devices, which are mentioned prominently in both videos.
Feature | October 01, 2018 | Dave Fornell, Editor
October 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC...
Image courtesy of St. Louis Children's and Washington University Heart Center
News | Congenital Heart | September 25, 2018
September 25, 2018 — Five-month-old Jack Palmer is home with his family in Kansas City after undergoing an extremely...
News | Cardiovascular Surgery | September 06, 2018
September 6, 2018 — While it is firmly established that the use of one internal thoracic artery can improve life...
News | Ventricular Assist Devices (VAD) | May 23, 2018
May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3...
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018
May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...
News | Heart Valve Technology | March 30, 2018
March 30, 2018 — LivaNova PLC announced the first patient enrollment in the Perceval Valve...
News | Magnetic Resonance Imaging (MRI) | February 27, 2018
February 27, 2018 – A new study published in the Journal of the American College of Cardiology confirms non-invasive...
